Activist BIMIZCI Fund Intensifies Proxy Battle, Alleges CEO Fraud & Excessive Severance Ahead of Vote
MFIN sits 22% above its 52-week low of $7.85.
Summary
Activist investor BIMIZCI Fund LLC released a detailed rebuttal to Medallion Financial's defense, leveling serious allegations against CEO Andrew Murstein and questioning executive compensation and financial performance just days before the annual meeting.
Key Events · Corporate Governance and Compliance · MFIN
-
Proxy Battle Escalates
Activist BIMIZCI Fund LLC released a detailed rebuttal, accusing Medallion Financial's management of distortion and highlighting governance failures.
-
Serious CEO Allegations
The filing details allegations of fraud, financial improprieties, and permanent federal injunctions against CEO Andrew Murstein, questioning his promotion.
-
Excessive Severance Concerns
BIMIZCI highlights a potential $28 million severance package for five executives, representing over 10% of the company's current market capitalization.
-
Financial Performance Criticized
The activist points to Medallion's lowest Q1 earnings in five years, high recreation loan charge-offs, and an "abysmal" price-to-tangible book value.
Analysis · MFIN · Finance
This filing represents a critical escalation in the ongoing proxy contest, with activist BIMIZCI Fund LLC presenting a comprehensive attack on Medallion Financial's management and board. The allegations of fraud and federal injunctions against CEO Andrew Murstein, coupled with concerns over a potential $28 million executive severance package (over 10% of market cap), directly challenge the company's governance and financial integrity. Coming just days before the annual shareholder meeting on June 9, 2026, and following endorsements for BIMIZCI's nominees from ISS and Glass Lewis, this filing aims to sway undecided votes and could lead to significant changes in the company's leadership and strategic direction.
At the time of this filing, MFIN was trading at $9.56 on NASDAQ in the Finance sector, with a market capitalization of approximately $228M. The 52-week trading range was $7.85 to $11.00. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.